| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 431.784 | 503.452 | 432.872 | 306.559 | 337.147 | 299.419 | 324.113 | 312.030 | 343.369 | 316.994 |
| Total Income - EUR | 434.856 | 506.481 | 450.428 | 321.671 | 341.311 | 311.603 | 334.835 | 320.756 | 344.441 | 317.957 |
| Total Expenses - EUR | 422.226 | 503.895 | 449.944 | 338.128 | 356.574 | 311.062 | 333.378 | 311.776 | 337.522 | 316.220 |
| Gross Profit/Loss - EUR | 12.629 | 2.586 | 484 | -16.456 | -15.263 | 541 | 1.457 | 8.981 | 6.920 | 1.737 |
| Net Profit/Loss - EUR | 10.594 | 2.089 | 341 | -17.104 | -15.263 | 454 | 1.224 | 8.043 | 5.792 | 1.166 |
| Employees | 7 | 7 | 7 | 6 | 5 | 5 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Ninurex Com Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.445 | 2.620 | 13.896 | 11.634 | 8.479 | 5.445 | 22.791 | 15.109 | 10.030 | 11.528 |
| Current Assets | 285.515 | 289.268 | 200.079 | 145.588 | 99.494 | 97.715 | 90.103 | 75.569 | 79.516 | 78.698 |
| Inventories | 238.785 | 219.580 | 171.070 | 120.955 | 73.425 | 60.940 | 64.151 | 54.141 | 58.841 | 58.507 |
| Receivables | 42.682 | 31.351 | 25.085 | 20.922 | 21.634 | 30.248 | 21.070 | 10.155 | 16.863 | 13.477 |
| Cash | 4.048 | 38.337 | 3.924 | 3.711 | 4.435 | 6.527 | 4.882 | 11.273 | 3.812 | 6.714 |
| Shareholders Funds | 207.114 | 207.091 | 82.630 | 64.009 | 47.507 | 47.061 | 47.241 | 49.416 | 55.059 | 55.917 |
| Social Capital | 147.155 | 145.654 | 21.892 | 21.490 | 21.074 | 20.675 | 20.216 | 20.279 | 20.217 | 20.104 |
| Debts | 82.846 | 84.798 | 130.017 | 92.188 | 59.736 | 55.652 | 65.478 | 41.261 | 34.487 | 34.309 |
| Income in Advance | 0 | 0 | 1.328 | 1.024 | 731 | 448 | 175 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4532 - 4532" | |||||||||
| CAEN Financial Year |
4532
|
|||||||||
Comments - Ninurex Com Srl